Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantin Dreher

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Acta Oncologica (Stockholm, Sweden)|April 5, 2023
Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysisConstantin Dreher, Gustavo R Sarria, Georgia Miebach, et al.
Scientific Reports|May 7, 2025
Longitudinal stability of HyperSight<sup>TM</sup>-CBCT based radiomic features in patients with CT guided adaptive SBRT for prostate cancerPaula Cvachovec, Alicia S Bicu, Ralf Schmidt, et al.
Scientific Reports|April 11, 2026
Feasibility of automated AI-based contouring and stable radiomic feature assessment by HyperSight-CBCT Imaging for adaptive high-precision radiotherapy of prostate cancerRalf Schmidt, Dion Bajerski, Alicia S Bicu, et al.
Anticancer Research|March 27, 2026
Advanced Reliability of Radiomic Features in <i>Ex Vivo</i> Hypersight<sup>TM</sup>-CBCT Imaging by iCBCT-Acuros ReconstructionVictor Siefert, Florian Haag, Alicia S Bicu, et al.
Radiation Oncology (London, England)|October 16, 2025
Advanced HyperSight™ imaging for patients with adaptive SBRT of prostate cancer: a longitudinal analysis of tissue demarcationRalf Schmidt, Thanh Nguyen, Alicia S Bicu, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 23, 2018
Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic locationConstantin Dreher, Johanna Oberhollenzer, Jan-Eric Meissner, et al.
Oncology Research and Treatment|September 5, 2025
Structured magnetic resonance imaging assessment improves diagnosis of pathological complete response in rectal cancer after neoadjuvant chemoradiationMoying Li, Tobias Dieckmann, Florian Herrle, et al.
Neuro-Oncology|May 8, 2018
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 TDaniel Paech, Johannes Windschuh, Johanna Oberhollenzer, et al.
European Radiology|February 28, 2019
Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patientsDaniel Paech, Constantin Dreher, Sebastian Regnery, et al.
Radiation Oncology (London, England)|May 29, 2026
HyperSight<sup>TM</sup>-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility studyVictor Siefert, Joana V Bettenhausen, Alicia S Bicu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|April 5, 2023
Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysisConstantin Dreher, Gustavo R Sarria, Georgia Miebach, et al.
Scientific Reports|May 7, 2025
Longitudinal stability of HyperSight<sup>TM</sup>-CBCT based radiomic features in patients with CT guided adaptive SBRT for prostate cancerPaula Cvachovec, Alicia S Bicu, Ralf Schmidt, et al.
Scientific Reports|April 11, 2026
Feasibility of automated AI-based contouring and stable radiomic feature assessment by HyperSight-CBCT Imaging for adaptive high-precision radiotherapy of prostate cancerRalf Schmidt, Dion Bajerski, Alicia S Bicu, et al.
Anticancer Research|March 27, 2026
Advanced Reliability of Radiomic Features in <i>Ex Vivo</i> Hypersight<sup>TM</sup>-CBCT Imaging by iCBCT-Acuros ReconstructionVictor Siefert, Florian Haag, Alicia S Bicu, et al.
Radiation Oncology (London, England)|October 16, 2025
Advanced HyperSight™ imaging for patients with adaptive SBRT of prostate cancer: a longitudinal analysis of tissue demarcationRalf Schmidt, Thanh Nguyen, Alicia S Bicu, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 23, 2018
Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic locationConstantin Dreher, Johanna Oberhollenzer, Jan-Eric Meissner, et al.
Oncology Research and Treatment|September 5, 2025
Structured magnetic resonance imaging assessment improves diagnosis of pathological complete response in rectal cancer after neoadjuvant chemoradiationMoying Li, Tobias Dieckmann, Florian Herrle, et al.
Neuro-Oncology|May 8, 2018
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 TDaniel Paech, Johannes Windschuh, Johanna Oberhollenzer, et al.
European Radiology|February 28, 2019
Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patientsDaniel Paech, Constantin Dreher, Sebastian Regnery, et al.
Radiation Oncology (London, England)|May 29, 2026
HyperSight<sup>TM</sup>-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility studyVictor Siefert, Joana V Bettenhausen, Alicia S Bicu, et al.
Pageof 4